7Baggers
 published on: 2025-11-14 19:58:18  newser.com Sat, 15 Nov 2025 01:58:18 GMT
 published on: 2025-11-14 17:28:35  newser.com Fri, 14 Nov 2025 23:28:35 GMT
 greenwich lifesciences, inc. sec 10-q report  TradingView Fri, 14 Nov 2025 21:37:29 GMT
 Published on: 2025-11-14 13:13:03  newser.com Fri, 14 Nov 2025 19:13:03 GMT
 Published on: 2025-11-13 03:10:11  newser.com Thu, 13 Nov 2025 09:10:11 GMT
 Greenwich LifeSciences CEO Makes Bold Stock Purchase!  TipRanks Thu, 13 Nov 2025 02:58:50 GMT
 published on: 2025-11-10 09:06:18  newser.com Mon, 10 Nov 2025 15:06:18 GMT
 published on: 2025-11-10 07:05:57  newser.com Mon, 10 Nov 2025 13:05:57 GMT
 published on: 2025-11-10 02:07:19  newser.com Mon, 10 Nov 2025 08:07:19 GMT
 published on: 2025-11-10 00:18:55  newser.com Mon, 10 Nov 2025 06:18:55 GMT
 published on: 2025-11-09 14:08:16  newser.com Sun, 09 Nov 2025 20:08:16 GMT
 published on: 2025-11-09 13:08:04  newser.com Sun, 09 Nov 2025 19:08:04 GMT
 published on: 2025-11-09 07:05:13  newser.com Sun, 09 Nov 2025 13:05:13 GMT
 Liquidity Mapping Around (GLSI) Price Events  news.stocktradersdaily.com Thu, 06 Nov 2025 14:26:03 GMT
 published on: 2025-11-05 22:11:10  newser.com Thu, 06 Nov 2025 04:11:10 GMT
 published on: 2025-11-05 03:57:04  newser.com Wed, 05 Nov 2025 09:57:04 GMT
 top executive makes bold move with major stock purchase!  TipRanks Wed, 05 Nov 2025 09:07:34 GMT
 published on: 2025-11-04 05:25:47  newser.com Tue, 04 Nov 2025 11:25:47 GMT
 published on: 2025-11-04 04:33:58  newser.com Tue, 04 Nov 2025 10:33:58 GMT
 published on: 2025-11-04 04:01:25  newser.com Tue, 04 Nov 2025 10:01:25 GMT
 Patel buys Greenwich LifeSciences (GLSI) shares worth $21,298  Investing.com Tue, 04 Nov 2025 08:00:00 GMT
 Top Executive Makes Bold Move with Major Stock Purchase!  TipRanks Tue, 04 Nov 2025 08:00:00 GMT
 published on: 2025-11-03 06:25:10  newser.com Mon, 03 Nov 2025 12:25:10 GMT

Greenwich LifeSciences, Inc
(NASDAQ:GLSI) 

GLSI stock logo

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other human epidermal growth factor receptor 2/neu-expressing (HER2/neu) cancers. Its lead product candidate is the GP2, an immunotherapy, which ...

Founded: 2006
CEO: Snehal Patel  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends